GAA
INO icon

Green Alpha Advisors’s Inovio Pharmaceuticals INO Stock Holding History

Green Alpha Advisors’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$140K Buy
114,857
+46,802
+69% +$52.2K 0.09% 102
2026
Q2 		$74.9K Buy
68,055
+2,475
+4% +$2.94K 0.05% 110
2026
Q1 		$114K Sell
65,580
-6,515
-9% -$10.7K 0.11% 100
2025
Q4 		$125K Buy
72,095
+24,007
+50% +$52.9K 0.11% 109
2025
Q3 		$113K Sell
48,088
-5,220
-10% -$9.99K 0.11% 97
2025
Q2 		$108K Sell
53,308
-7,953
-13% -$15.2K 0.1% 100
2025
Q1 		$99.9K Sell
61,261
-4,185
-6% -$8.4K 0.11% 102
2024
Q4 		$120K Buy
65,446
+33,232
+103% +$147K 0.1% 140
2024
Q3 		$186K Sell
32,214
-871
-3% -$7.18K 0.15% 124
2024
Q2 		$267K Sell
33,085
-3,332
-9% -$35.1K 0.21% 109
2024
Q1 		$505K Sell
36,417
-1,227
-3% -$10.6K 0.37% 98
2023
Q4 		$230K Sell
37,644
-9,860
-21% -$48.7K 0.17% 142
2023
Q3 		$222K Buy
47,504
+32,313
+213% +$178K 0.17% 139
2023
Q2 		$81.4K Buy
15,191
+2,999
+25% +$24.2K 0.05% 147
2023
Q1 		$120K Sell
12,192
-64
-0.5% -$1.09K 0.08% 140
2022
Q4 		$229K Sell
12,256
-26
-0.2% -$589 0.19% 127
2022
Q3 		$254K Buy
12,282
+1,399
+13% +$35.8K 0.22% 129
2022
Q2 		$226K Buy
10,883
+4,284
+65% +$121K 0.05% 142
2022
Q1 		$284K Buy
6,599
+545
+9% +$24.6K 0.19% 125
2021
Q4 		$363K Buy
6,054
+623
+11% +$49.9K 0.25% 117
2021
Q3 		$467K Buy
5,431
+217
+4% +$21.8K 0.32% 119
2021
Q2 		$580K Buy
+5,214
New +$501K 0.39% 112

Other funds holding INO

FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
BAM
Byrne Asset Management Kingston, New Jersey $179M AUM 29.67% 1-Year Est. Return

Green Alpha Advisors's INO Position: Q3 2026 in Review

Green Alpha Advisors increased its Inovio Pharmaceuticals (INO) stake by 69% in Q3 2026, buying an estimated $52.2K and bringing the position to 114,857 shares worth $140K. The position accounts for 0.09% of the portfolio, ranked #102.

Green Alpha Advisors first reported a position in INO in Q2 2021 and has held it in 22 quarters since. The position peaked at $580K in Q2 2021. 5 funds tracked by Wall St. Rank hold INO as of Q3 2026.

  • Green Alpha Advisors held 114,857 shares of Inovio Pharmaceuticals worth $140K as of Q3 2026.
  • Green Alpha Advisors bought 46,802 Inovio Pharmaceuticals shares in Q3 2026, an estimated $52.2K.
  • Inovio Pharmaceuticals made up 0.09% of Green Alpha Advisors's portfolio in Q3 2026, its #102 holding.
  • Green Alpha Advisors first reported a position in Inovio Pharmaceuticals in Q2 2021 and has held it in 22 quarters since.
  • Green Alpha Advisors's Inovio Pharmaceuticals position peaked at $580K in Q2 2021.
  • 5 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2026.

Based on Green Alpha Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.